Diabetes Mellitus, Type 1  >>  BIAsp 30 (biphasic insulin aspart 30/70 biosimilar)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BIAsp 30 (biphasic insulin aspart 30/70 biosimilar) / Novo Nordisk
NCT01467323: Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Completed
3
303
Europe
biphasic insulin aspart, biphasic human insulin
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
09/98
09/98
NCT01486381: Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes

Completed
3
22
RoW
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1
05/03
05/03
NCT00617565: Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes

Completed
3
219
RoW
biphasic insulin aspart, BIASP, biphasic human insulin
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
11/03
11/03

Download Options